Hydroxypropylmethylcellulose and methylcellulose consumption reduce postprandial insulinemia in overweight and obese men and women

Journal of Nutrition

Volumn 138, Issue 2, 2008, Pages 292-296

  Maki, Kevin C ^a   Carson, Michael L ^b   Miller, Marvin P ^b   Turowski, Maciej ^b   Bell, Marjorie ^a   Wilder, Donna M ^a   Rains, Tia M ^a   Reeves, Matthew S ^a  

^a Provident Clinical Research   (United States)

^b DOW CHEMICAL COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYPROPYLMETHYLCELLULOSE; METHYLCELLULOSE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOOD INTAKE; GLUCOSE ABSORPTION; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESPONSE; INSULINEMIA; MALE; OBESITY; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; VISCOSITY;

EID: 38949141953     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.1093/jn/138.2.292     Document Type: Article

References (40)

1. Blackburn NA, Redfern JS, Jarjis H, Holgate AM, Hanning I, Scarpello JH, Johnson IT, Read NW. The mechanism of action of guar gum in improving glucose tolerance in man. Clin Sci. 1984;66:329-36.
2. Jenkins DJ, Wolever TM, Leeds AR, Gassull MA, Haisman P, Dilawari J, Goff DV, Metz GL, Alberti KG. Dietary fibres, fibre analogues, and glucose tolerance: importance of viscosity. BMJ. 1978;1:1392-4.
3. Pastors JG, Blaisdell PW, Balm TK, Asplin CM, Pohl SL. Psyllium fiber reduces rise in postprandial glucose and insulin concentrations in patients with non-insulin-dependent diabetes. Am J Clin Nutr. 1991;53:1431-5.
4. Wood PJ, Braaten JT, Scott FW, Riedel KD, Wolynetz MS, Collins MW. Effect of dose and modification of viscous properties of oat gum on plasma glucose and insulin following an oral glucose load. Br J Nutr. 1994;72:731-43.
5. Leclere CJ, Champ M, Boillot J, Guille G, Lecannu G, Molis C, Bornet F, Krempf M, Delort-Laval J, et al. Role of viscous guar gums in lowering the glycemic response after a solid meal. Am J Clin Nutr. 1994;59:914-21.
6. Wolever TM, Vuksan V, Eshuis H, Spadafora P, Peterson RD, Chao ES, Storey ML, Jenkins DJ. Effect of method of administration of psyllium on glycemic response and carbohydrate digestibility. J Am Coll Nutr. 1991;10:364-71.
7. Van de Laar FA, Lucassen PL, Akkermans RP, Van de Lisdonk EH, De Grauw WJC. Alpha-glucosidase inhibitors for people with impaired glucose tolerance or impaired fasting blood glucose. Cochrane Database Syst Rev. 2006;CD005061: 10.1002/14651858.pub2.
8. Willett W, Manson J, Liu S. Glycemic index, glycemic load, and risk of type 2 diabetes. Am J Clin Nutr. 2002;76 Suppl:S274-80.
9. Maki KC, Carson ML, Miller MP, Turowski M, Wilder DM, Bell M, Ratcliff N, Reeves MS. High-viscosity hydroxypropylmethylcellulose blunts postprandial glucose and insulin responses. Diabetes Care. 2007;30:1039-43.
10. Schulze MB, Liu S, Rimm EB, Manson JE, Willett WC, Hu FB. Glycemic index, glycemic load, and dietary fiber intake and incidence of type 2 diabetes in younger and middle-aged women. Am J Clin Nutr. 2004;80:348-56.
11. Maki KC, Rains TM, Kaden VM, Raneri KR, Davidson MH. Effects of a reduced-glycemic-load diet on body weight, body composition, and cardiovascular disease risk markers in overweight and obese adults. Am J Clin Nutr. 2007;85:724-34.
12. DeFronzo RA, Ferrannini E. Pathogenesis of NIDDM: a balanced overview. Diabetes Care. 1992;15:318-68.
13. Maki K. Dietary factors in the prevention of diabetes mellitus and coronary artery disease associated with the metabolic syndrome. Am J Cardiol. 2004;93 Suppl:C12-7
14. Van de Laar FA, Lucassen PL, Akkermans RP, Van de Lisdonk EH, Rutter GE, Van Weel C. Alpha-glucosidase inhibitors for patients with type 2 diabetes. Diabetes Care. 2005;28:154-62.
15. Chiasson J, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIFFM randomization trial. Lancet. 2002;359:2072-7.
16. Chiasson J, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA. 2003;290:486-94.
17. Hanefeld M, Chiasson JL, Koehler C, Henkel E, Schaper F, Temelkova-Kurktschiev T. Acarbose slows progression of intima-media thickness of the carotid arteries in subjects with impaired glucose tolerance. Stroke. 2004;35:1073-8.
18. Reppas C, Meyer JH, Sirois PJ, Dressman JB. Effects of hydroxypropylmethylcellulose on gastrointestinal transit and luminal viscosity in dogs. Gastroenterology. 1991;100:1217-23.
19. Reppas C, Greenwood DE, Dressman JB. Longitudinal versus radial effects of hydroxypropyl-methylcellulose on gastrointestinal glucose absorption in dogs. Eur J Pharm Sci. 1999;8:211-9.
20. Reppas C, Adair CH, Barnett JL, Berardi RR, DuRoss D, Swidan SZ, Thill PF, Tobey SW, Dressman JB. High viscosity hydroxypropylmethylcellulose reduces postprandial blood glucose concentrations in NIDDM patients. Diabetes Res Clin Pract. 1993;22:61-9.
21. Buemann B, Toubro S, Ruben A, Astrup A. Human tolerance to a single, high dose of D-tagatose. Regul Toxicol Pharmacol. 1999;29:S66-70.
22. Kadish AH, Hall DA. A new method for the continuous monitoring of blood glucose by measurement of dissolved oxygen. Clin Chem. 1965;11:869-75.
23. Allauzen SM, Joly S, Granier C, Molina F, Boulx O, Pau B, Bouanani M. Immunoanalysis of human insulin using monoclonal antibodies reveals antigenicity of evolutionarily conserved residues. Mol Immunol. 1995;32:27-36.
24. Pocock SJ. Clinical trials: a practical approach. London: Wiley Publications; 1987.
25. Shapiro SS, Wilk MB. An analysis of variance test for normality. Biometrika. 1965;52:591-611.
26. Reppas C, Dressman JB. Viscosity modulates blood glucose response to nutrient solutions in dogs. Diabetes Res Clin Pract. 1992;17:81-8.
27. Topping DL, Oakenfull D, Trimble RP, Illman RJ. A viscous fibre (methylcellulose) lowers blood glucose and plasma triglycerols and increases liver glycogen independently of volatile fatty acid production in the rat. Br J Nutr. 1988;59:21-30.
28. Jenkins DJ, Kendall CW, Augustin LS, Vuksan V. High-complex carbohydrate or lente carbohydrate foods? Am J Med. 2002;113 Suppl 9B:S30-7.
29. Kirkman MS, Shankar RR, Shankar S, Shen C, Brizendine E, Baron A, McGill J. Treating postprandial hyperglycemia does not appear to delay progression of early type 2 diabetes: the Early Diabetes Intervention Program. Diabetes Care. 2006;29:2095-101.
30. Ford ES, Abbasi F, Reaven GM. Prevalence of insulin resistance and the metabolic syndrome with alternative definitions of impaired glucose. Atherosclerosis. 2005;181:143-8.
31. Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, Haase N, Ho M, Howard V, et al. for the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics - 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2007;115:e69-171.
32. Olson BH, Anderson SM, Becker MP, Anderson JW, Hunninghake DB, Jenkins DJ, LaRosa JC, Rippe JM, Roberts DW, et al. Psyllium-enriched cereals lower blood total cholesterol and LDL cholesterol, but not HDL cholesterol, in hypercholesterolemic adults: results of a meta-analysis. J Nutr. 1997;127:1973-80.
33. Brown L, Roener B, Willett WW, Sacks FM. Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr. 1999;69:30-42.
34. Maki KC, Davidson MH, Malik KC, Albrecht HH, O'Mullane J, Daggy BP. Cholesterol lowering with high-viscosity hydroxypropylmethylcellulose. Am J Cardiol. 1999;84:1198-203.
35. Maki KC, Davidson MH, Torro S, Ingram KA, O'Mullane J, Daggy BP, Albrecht HH. High- molecular weight hydroxypropylmethylcellulose taken with or between meals is hypocholesterolemic in adult men. J Nutr. 2000;130:1705-10.
36. Dressman JB, Adair CH, Barnett JL, Berardi RR, Dunn-Kucharski VA, Jarvenpaa KM, Parr DD, Sowle CA, Swidan SZ, et al. High molecular-weight hydroxypropylmethylcellulose. A cholesterol-lowering agent. Arch Intern Med. 1993;153:1345-53.
37. Executive summary of the Third Report of the National Cholesterol Program Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-97.
38. Ellis PR, Dawoud FM. Blood glucose, plasma insulin and sensory responses to guar-containing wheat breads: effects of molecular weight and particle size of guar gum. Br J Nutr. 1991;66:363-79.
39. Bianchi M, Capurso L. Effects of guar gum, ispaghula and microcrystalline cellulose on abdominal symptoms, gastric emptying, orocaecal transit time and gas production in healthy volunteers. Dig Liver Dis. 2002;34:S129-33.
40. Wyatt GM, Horn N, Gee JM, Johnson IT. Intestinal microflora and gastrointestinal adaptation in the rat in response to non-digestible dietary polysaccharides. Br J Nutr. 1988;60:197-207.